Elevra Lithium has sold its rights and obligations on the E45/2364 pegmatite project in Western Australia to Wildcat Resources for A$16 million in cash and shares, plus ongoing royalties if Wildcat defines a mineral resource. The deal includes immediate cash payments, shares, deferred cash after a feasibility study, and contingent payments based on resource tonnage. This sale allows Elevra to focus on its core North American lithium assets while retaining potential upside through royalties. The transaction simplifies Elevra's portfolio and provides capital for growth initiatives in North America.
The 2026 National ORBIE Awards recognized outstanding leadership among chief information officers (CIOs) and chief information security officers (CISOs) across 11 categories, celebrating executives from major global and enterprise organizations. Winn...
RaceTrac has launched its fourth annual Beat The Freeze Sweepstakes, offering one grand prize winner the opportunity to race The Freeze mascot at the Atlanta Braves game on September 12, 2026, plus a $1,000 gift card and other perks. Participants can...
Digital Realty, the largest cloud- and carrier-neutral data center platform, supports Texas Governor Abbott's initiative for responsible and transparent data center investment in Texas. The company emphasizes collaboration with officials and communit...
Verisk Analytics CEO Lee Shavel has sold 2,500 shares of the company, generating $550,000 from the transaction. This sale may indicate personal portfolio adjustments or strategic financial planning by the CEO. Investors might watch for any further in...
Replimune Group Inc. received FDA approval for Tudriqev, its first drug targeting a difficult form of skin cancer, marking a major milestone for the biotech company. Despite earlier rejections and concerns over clinical data quality, the FDA granted ...
